Evaluation the Progesterone and Estrogen Receptor (PR & ESR) Level and Their Role in Medical Treatment of Patients with Endometriosis
Abstract Background As the endometriosis is a hormone dependent disease, this study designed to determine a cut-off point for selecting the appropriate treatment based on the hormone receptors of endometriosis lesions. Methods In this retrospective cohort study, all symptomatic endometriotic patients, between March 2017 to March 2019, was divided into two groups: responding and non-responding to hormone therapy following endometriosis surgery. Pathological slides of 72 patients were immunohistologically evaluated for progesterone (PR) and estrogen receptor (ESR) levels. Results Based on the rock curve, the presence of 70% of estrogen (P value: 0.001) and 80% of progesterone receptors (P value = 0.005), as well as 60% estrogen (P value: 0.1065) and 40% of progesterone receptors (P value: 0.1699) in the pathology sample based on H score can predict the appropriate response to hormonal treatment of dyspareunia and dysmenorrhea respectively. Dysmenorrhea in the presence of endometrioma showed the best response to OCP compared to the progesterone treatment (69.4% versus 27.8%), while the response of dyspareunia in the presence of the DIE lesions showed the best response to progesterone treatment (75% versus 27.8%). Conclusion Response to treatment of dysmenorrhea and dyspareunia is directly related to the increase of H score. Gynecologist can make the right hormonal treatment based on the specific pattern of IHC staining obtained from patients 'surgical specimens, which leads to improved quality of life and also effective pain reduction after operation as well as recurrent rate.